STOCK TITAN

Exact Sciences to participate in September investor conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Exact Sciences Corp. (Nasdaq: EXAS) announced its participation in the Baird Global Healthcare Conference set for September 13, 2022, at 3:45 p.m. ET. Investors can join the fireside chat via webcast on Exact Sciences' investor relations website. The company focuses on innovative cancer screening and diagnostic solutions, enhancing its product pipeline, including Cologuard® and Oncotype® tests, to support patients through their cancer journeys. For more details, visit www.exactsciences.com.

Positive
  • None.
Negative
  • None.

MADISON, Wis., Sept. 1, 2022 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conference and invited investors to participate by webcast.

  • Baird Global Healthcare Conference, New York
    Fireside chat on Tuesday, September 13, 2022 at 3:45 p.m. ET

The webcast can be accessed in the investor relations section of Exact Sciences' website at www.exactsciences.com.

About Exact Sciences Corp.
A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smarter solutions providing the clarity to take life-changing action, earlier. Building on the success of Cologuard® and Oncotype® tests, Exact Sciences is investing in its product pipeline to support patients before and throughout their cancer diagnosis and treatment. Exact Sciences unites visionary collaborators to help advance the fight against cancer. For more information, please visit the company's website at www.exactsciences.com, follow Exact Sciences on Twitter @ExactSciences, or find Exact Sciences on Facebook.

Contact:
Megan Jones
Exact Sciences Corp.
meganjones@exactsciences.com
608-535-8815

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/exact-sciences-to-participate-in-september-investor-conference-301615980.html

SOURCE Exact Sciences Corporation

FAQ

What event will Exact Sciences participate in on September 13, 2022?

Exact Sciences will take part in the Baird Global Healthcare Conference on September 13, 2022.

What time will the Exact Sciences conference fireside chat take place?

The fireside chat will be held at 3:45 p.m. ET.

How can investors access the Exact Sciences conference webcast?

Investors can access the webcast in the investor relations section of Exact Sciences' website.

What is the primary focus of Exact Sciences Corp.?

Exact Sciences focuses on developing innovative cancer screening and diagnostic tests.

What products are mentioned in the Exact Sciences press release?

The press release mentions Cologuard® and Oncotype® tests.

Exact Sciences Corp

NASDAQ:EXAS

EXAS Rankings

EXAS Latest News

EXAS Stock Data

9.16B
182.40M
1.01%
100.86%
7.6%
Diagnostics & Research
Services-medical Laboratories
Link
United States of America
MADISON